Orexo AB (OSTO:ORX) Days Sales Outstanding : 128.33 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Days Sales Outstanding?

Orexo AB's average Accounts Receivable for the three months ended in Dec. 2023 was kr233.5 Mil. Orexo AB's Revenue for the three months ended in Dec. 2023 was kr166.0 Mil. Hence, Orexo AB's Days Sales Outstanding for the three months ended in Dec. 2023 was 128.33.

The historical rank and industry rank for Orexo AB's Days Sales Outstanding or its related term are showing as below:

OSTO:ORX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.04 Med: 111.13 Max: 138.27
Current: 138.27

During the past 13 years, Orexo AB's highest Days Sales Outstanding was 138.27. The lowest was 57.04. And the median was 111.13.

OSTO:ORX's Days Sales Outstanding is ranked worse than
88.01% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs OSTO:ORX: 138.27

Orexo AB's Days Sales Outstanding declined from Dec. 2022 (158.40) to Dec. 2023 (128.33).

Orexo AB Days Sales Outstanding Historical Data

The historical data trend for Orexo AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Days Sales Outstanding Chart

Orexo AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

107.65

109.73

122.48

134.62

126.88

Orexo AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															158.40	141.41	143.56	151.93	128.33

Competitive Comparison of Orexo AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orexo AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orexo AB's Days Sales Outstanding falls into.

Orexo AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orexo AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (246.5	+	197.6)	/	2 )	/	638.8	*	365
=	222.05					/	638.8	*	365
=	126.88

Orexo AB's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (269.3	+	197.6)	/	2 )	/	166	*	365 / 4
=	233.45					/	166	*	365 / 4
=	128.33

Orexo AB (OSTO:ORX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orexo AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orexo AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB (OSTO:ORX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ORXOY:USA ORXOF:USA 0H19:UK C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments US Pharma, Digital Therapeutics (DTx) and HQ & Pipeline. The majority is from the US Pharma segment. Geographically, the majority is derived from the United States. US Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline include the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB (OSTO:ORX) Headlines

No Headlines